Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine versus naproxen for acute gout
ISRCTN69836939Phase 4Completed
- Sponsor
- University of Keele (UK)
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4, randomised trial in gout comparing Low-dose colchicine with Naproxen (2 arms). Primary endpoint: Pain intensity. Started Jan 2014; status: completed.
02
Drugs
colchicinenaproxen
03
Conditions
gout
Beyond the preview
Go deeper on ISRCTN69836939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69836939.